-- Scott Roberts
TUESDAY, Feb. 28 (HealthDay News) -- A pen-delivery version of
the multiple sclerosis drug Avonex has been approved by the U.S.
Food and Drug Administration, drug manufacturer Biogen Idec said
The self-administering Avonex autoinjector pen is designed to
lessen pain and anxiety associated with MS, the
Associated Press reported.
The drug was first approved in 1996. On Tuesday, the FDA also
approved new dosing guidelines to help cut down on flu-like
symptoms, a common adverse reaction to the drug, the
Biogen Idec is based in Weston, Mass.
Medline Plus has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.